Three New Breast Cancer Susceptibility SNPs Identified

This article originally appeared here.
Share this content:
Three New Breast Cancer Susceptibility SNPs Identified
Three New Breast Cancer Susceptibility SNPs Identified

(HealthDay News) – Three new single nucleotide polymorphisms (SNPs) conferring susceptibility to breast cancer have been identified, according to a letter published online January 22 in Nature Genetics.

Maya Ghoussaini, PhD, from the University of Cambridge in the United Kingdom, and colleagues investigated additional loci associated with susceptibility to breast cancer. They performed genotyping to investigate the association for each of 72 SNPs previously associated with breast cancer in 69,564 cases and 68,150 controls from 41 case-control studies and nine genome-wide association studies.

The researchers found three loci significantly associated with breast cancer risk located at 12p11 (rs10771399), 12q24 (rs1292011), and 21q21 (rs2823093). The 12p11 SNP (rs10771399) correlated with similar relative risks for estrogen receptor-positive and estrogen receptor-negative cancer. The other SNPs (rs1292011 and rs2823093) correlated with a higher risk of estrogen receptor-positive cancer.

"The three susceptibility variants newly identified in this study are relatively common (minor allele frequencies of 0.11 to 0.41) and together explain ~0.7 percent of the familial risk of breast cancer and bring the total contribution of common low-penetrance breast cancer susceptibility loci to ~9 percent," the authors write. "The relative risks associated with these variants are modest, with the per-allele odds ratios for the risk alleles ranging from 1.07- to 1.22-fold, but the causal variants underlying some of these loci might confer more substantial risks."

Abstract
Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs